Stay updated on HBI-8000 + Nivolumab vs. Nivolumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the HBI-8000 + Nivolumab vs. Nivolumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the HBI-8000 + Nivolumab vs. Nivolumab in Melanoma Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    Change Detected
    Summary
    The website has been updated to version 2.10.0, introducing new features for viewing and comparing study record versions.
    Difference
    6%
    Check dated 2024-07-23T14:57:54.000Z thumbnail image
  5. Check
    5 days ago
    No Change Detected
  6. Check
    11 days ago
    Change Detected
    Summary
    The website has been updated to Revision v2.9.7 from v2.9.6.
    Difference
    0.3%
    Check dated 2024-07-16T08:38:59.000Z thumbnail image
  7. Check
    25 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent revision in the content or details of the webpage.
    Difference
    0.3%
    Check dated 2024-07-02T14:39:48.000Z thumbnail image
  8. Check
    30 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.3 to v2.9.5, indicating a recent revision in the content of the webpage.
    Difference
    0.3%
    Check dated 2024-06-27T10:30:26.000Z thumbnail image
  9. Check
    31 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.1 to v2.9.3, indicating a recent revision in the content or details of the webpage.
    Difference
    0.3%
    Check dated 2024-06-26T09:30:43.000Z thumbnail image
  10. Check
    32 days ago
    Change Detected
    Summary
    The study status has changed from 'Recruiting' to 'Active, not recruiting'. Additionally, the comparison in the study has been updated from 'HBI-8000 Combined With Nivolumab vs. Nivolumab' to 'HBI-8000 + Nivolumab vs. Placebo + Nivolumab' in patients with advanced melanoma.
    Difference
    3%
    Check dated 2024-06-25T08:41:32.000Z thumbnail image

Stay in the know with updates to HBI-8000 + Nivolumab vs. Nivolumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the HBI-8000 + Nivolumab vs. Nivolumab in Melanoma Clinical Trial page.